FDA Approved: ALYACEN 1/35 — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)

View source ↗

Summary

FDA approved a supplemental application for ALYACEN 1/35, a generic combination product of norethindrone and ethinyl estradiol for contraception.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Contraception

Drugs mentioned

• ALYACEN 1/35 (NORETHINDRONE AND ETHINYL ESTRADIOL)

Snippet

SUPPL AP for ALYACEN 1/35 (NORETHINDRONE AND ETHINYL ESTRADIOL)